HTL Biotechnology launches HTL8
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
This new edition marks an important milestone in our sustainability journey. It captures the concrete initiatives, strategic choices, and collective energy that have shaped our year. From reducing our environmental footprint to promoting diversity and inclusion, and strengthening dialogue with our stakeholders — every step we’ve taken is part of a long-term vision.
Discover the path HTL Biotechnology is taking to shape a more responsible and innovative future.
Happy reading!
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
HTL Biotechnology hosted a scientific summit in Chengdu, China, dedicated to PDRN/PN, bringing together more than 130 experts and professionals to discuss the latest scientific advances, regulatory developments and emerging applications.
Driven by the collective commitment of our teams, this report confirms the maturity of an internationally recognized approach, which was recognized this year with the EcoVadis Platinum medal, placing HTL Biotechnology among the top 1% of the world’s most committed companies.